US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: 31% Potential Upside Ignites Investor Interest

Genmab A/S (GMAB) is capturing the attention of investors with a compelling growth narrative in the biotechnology sector. Headquartered in Copenhagen, Denmark, Genmab specializes in developing innovative antibody-based treatments for..

STERIS plc (STE) Stock Analysis: Healthcare Giant Offers 17.99% Potential Upside

STERIS plc (NYSE: STE), a healthcare behemoth specializing in infection prevention products and services, continues to draw attention from investors with its compelling growth potential in the medical devices sector...

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Complex Financial Landscape with Strategic Insights

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, offers a comprehensive array of mission-critical products and services for a diverse client base that spans biopharma, healthcare, and..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 14.71% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is capturing investor attention with its diverse portfolio and promising market position. Headquartered in Franklin Lakes, New Jersey,..

McKesson Corporation (MCK) Stock Analysis: Evaluating the 12.44% Potential Upside

McKesson Corporation (NYSE: MCK) stands as a titan in the healthcare sector, with a market capitalization of $98.45 billion, underscoring its significant role in the medical distribution industry. Established in..

Insulet Corporation (PODD) Stock Analysis: Uncovering a 45.91% Potential Upside in the Medical Devices Sector

Insulet Corporation (NASDAQ: PODD) has positioned itself as a notable player in the healthcare sector, specifically within medical devices. Known for its innovative insulin delivery systems, Insulet’s products cater to..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring the 5.25% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH), a leading entity in the Diagnostics & Research industry, is drawing the attention of investors with its promising potential upside of 5.25%. As part of..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a Stable Path in Diagnostics & Research

Mettler-Toledo International, Inc. (NYSE: MTD), a key player in the Healthcare sector, specifically within the Diagnostics & Research industry, stands as a robust contender in the global precision instruments market...

Tenet Healthcare Corporation (THC) Stock Analysis: Robust Revenue Growth and Strong Buy Ratings Propel Investor Interest

Tenet Healthcare Corporation (NYSE: THC) is capturing the attention of investors with its impressive revenue growth and a resounding endorsement from analysts. As a key player in the healthcare sector,..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A 7.94% Upside Potential in the Healthcare Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a stalwart in the healthcare sector, specializing in the design, manufacture, and marketing of medical devices. With a market capitalization of $17.67 billion,..

Qiagen N.V. (QGEN) Stock Analysis: Uncovering the Growth Potential in Diagnostics & Research

Qiagen N.V. (QGEN), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is positioned as an intriguing investment opportunity from its base in Venlo, Netherlands...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Navigating Potential Upside with Strong Buy Ratings

Roivant Sciences Ltd. (NASDAQ: ROIV), a burgeoning force in the biotechnology sector, is making waves among investors with its promising pipeline of clinical-stage products. Despite the recent static price movement,..

Smith & Nephew SNATS, Inc. (SNN): Stock Analysis and Investor Outlook with 11.46% Potential Upside

Smith & Nephew SNATS, Inc. (SNN), a stalwart in the healthcare sector, specifically within the medical devices industry, is capturing investor interest with its promising potential upside of 11.46%. As..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unpacking a Potential 27% Upside for Investors

As investors search for stable opportunities in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) emerges as a compelling candidate. With a market capitalization of $25.44 billion, Philips has established..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a Healthcare Powerhouse with Impressive Return on Equity

Amgen Inc. (NASDAQ: AMGN) stands as a titan in the healthcare sector, particularly in the drug manufacturing industry. With a market capitalization of $202.95 billion, Amgen showcases a robust presence..

Novartis AG (NVS) Stock Analysis: Unpacking the Healthcare Giant’s Growth Potential and Dividend Appeal

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, is a Swiss-based pharmaceutical titan renowned for its innovative medicines. With a robust portfolio targeting areas such as oncology,..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 15% Upside Potential

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors. With a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 105.67% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a biotech firm headquartered in Miami, Florida, is capturing investor attention with a promising potential upside of 105.67%. With a market capitalization of $10.9 billion,..

Alcon Inc. (ALC) Stock Analysis: Strong Buy Ratings Signal 28% Potential Upside

Alcon Inc. (NYSE: ALC), a global leader in eye care, has captured investor attention with a robust portfolio and a significant potential upside of 28.58%, based on analyst forecasts. With..

Insmed Incorporated (INSM) Stock Analysis: Biotechnology Giant with 83% Upside Potential

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, has captured investor attention with its considerable market cap of $23.18 billion and a remarkable potential upside of 83.48%...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds